Ipilimumab vs Levodopa

## Ipilimumab vs Levodopa: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Levodopa**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Levodopa**: Metabolic precursor of dopamine that crosses the BBB.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Levodopa — 1.5 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Levodopa — C9H11NO4.

**Molecular Weight**: Ipilimumab — N/A; Levodopa — 197.1880 g/mol.

**Type**: Ipilimumab — Antibody; Levodopa — Small molecule.